Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.

Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases ...

The new AI is for use as a pre-plant burndown herbicide for agricultural use in canola, field corn, soybean, wheat, and ...

The firm, which had planned to submit a BLA in 2026 for AMT-130, described the FDA's latest feedback as a "drastic change" and "unexpected." ...

As you note in your editorial “The Spin Doctors at the FDA” (Oct. 28), the agency rejected Replimune ... a biologics ...

The Food and Drug Administration has designated Celltrion’s Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) as interchangeable biosimilars to Prolia and Xgeva, respectively, for all approved ...

Scilex’s shareholders as of the record date of November 14, 2025 will receive one meme coin for each common share held. This digital collectible is intended to provide for immutable recognition of ...

About NEXICART-2 NEXICART-2 (NCT06097832) is an ongoing multi-site U.S. Phase 1/2 clinical trial of sterically-optimized CAR-T NXC-201 in relapsed/refractory AL Amyloidosis, with a registrational ...

Successful completion of first trial phase enables continued pivotal trial of FemBloc, the only non-surgical permanent birth control, toward ...

The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct.

Your homes and garages may be hiding more than just clutter. They could contain products removed from store shelves for safety reasons. From tainted makeup wipes to adulterated prescription drugs, ...